Amgen AMGN
NASDAQ AMGN
$377.33 -5.14 (-1.34%)
As of: Sep 11, 2026 · 3:59 PM EDT

Amgen (AMGN) Amortization - Intangibles (2009 - 2012)

Amgen (AMGN) posted Amortization - Intangibles of $73.0 million for Q4 2012, down 1.35% on a QoQ basis from $74.0 million in Q3 2012, and little changed year-over-year from $73.0 million in Q1 2012.

Analysis

Amgen (AMGN) Amortization - Intangibles (2009 - 2012) Analysis & Trends

Amgen has reported Amortization - Intangibles for 4 years, with the latest figure at $73.0 million in Q4 2012.

  • On a quarterly basis, Amortization - Intangibles changed 0.0% year-over-year to $73.0 million in Q4 2012; TTM through Dec 2012 was $294.0 million, a 0.0% change from a year earlier, with the FY2012 full-year figure at $294.0 million, changed 0.0% from the prior year.
  • Amortization - Intangibles was $73.0 million for Q4 2012 at Amgen, down from $74.0 million in the prior quarter.
  • The five-year high for Amortization - Intangibles was $74.0 million in Q1 2009, with the low at $73.0 million in Q2 2009.
  • Average Amortization - Intangibles over 4 years is $73.5 million, with a median of $73.5 million recorded in 2009.
  • The largest YoY upside for Amortization - Intangibles was 0.0% in 2010 against a maximum downside of 0.0% in 2010.
  • Over 4 years, Amortization - Intangibles stood at $73.0 million in 2009, then changed by 0.0% to $73.0 million in 2010, then changed by 0.0% to $73.0 million in 2011, then changed by 0.0% to $73.0 million in 2012.
  • The last three Amortization - Intangibles figures came in at $73.0 million (Q4 2012), $74.0 million (Q3 2012), and $73.0 million (Q2 2012), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn
10 Insmed 28.06 Bn 26.90 Bn 358.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2012 73.00 Mn
Sep 30, 2012 74.00 Mn
Jun 30, 2012 73.00 Mn
Mar 31, 2012 74.00 Mn
Dec 31, 2011 73.00 Mn
Sep 30, 2011 74.00 Mn
Jun 30, 2011 73.00 Mn
Mar 31, 2011 74.00 Mn
Dec 31, 2010 73.00 Mn
Sep 30, 2010 74.00 Mn
Jun 30, 2010 73.00 Mn
Mar 31, 2010 74.00 Mn
Dec 31, 2009 73.00 Mn
Sep 30, 2009 74.00 Mn
Jun 30, 2009 73.00 Mn
Mar 31, 2009 74.00 Mn